Page last updated: 2024-10-26

3,3'-diindolylmethane and Glial Cell Tumors

3,3'-diindolylmethane has been researched along with Glial Cell Tumors in 2 studies

3,3'-diindolylmethane: anti-inflammatory from edible cruciferous vegetables; a cytochrome P-450 antagonist

Research Excerpts

ExcerptRelevanceReference
" Here we found that the phytochemical 3,3'-Diindolylmethane (DIM) can inhibit the growth and also the invasion of breast cancer, glioma, and non-small cell lung cancer cells regardless of which EGFR mutant is expressed and the drug-resistant phenotype."3.763,3'-Diindolylmethane (DIM) inhibits the growth and invasion of drug-resistant human cancer cells expressing EGFR mutants. ( Huang, KL; Rahimi, M; Tang, CK, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mattiazzi, J1
Sari, MHM1
Lautenchleger, R1
Dal PrĂ¡, M1
Braganhol, E1
Cruz, L1
Rahimi, M1
Huang, KL1
Tang, CK1

Other Studies

2 other studies available for 3,3'-diindolylmethane and Glial Cell Tumors

ArticleYear
Incorporation of 3,3'-Diindolylmethane into Nanocapsules Improves Its Photostability, Radical Scavenging Capacity, and Cytotoxicity Against Glioma Cells.
    AAPS PharmSciTech, 2019, Jan-07, Volume: 20, Issue:2

    Topics: Anticarcinogenic Agents; Cell Line, Tumor; Cytotoxins; Drug Stability; Free Radical Scavengers; Glio

2019
3,3'-Diindolylmethane (DIM) inhibits the growth and invasion of drug-resistant human cancer cells expressing EGFR mutants.
    Cancer letters, 2010, Sep-01, Volume: 295, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell

2010